bupranolol has been researched along with Angor Pectoris in 4 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of slow-release isosorbide-5-mononitrate (IS-5-MN), 25 mg once daily, bupranolol, 50 mg once daily, and their combination on exercise-induced ST-segment depression at comparable work load, maximal work load, exercise capacity, frequency of anginal episodes and sublingual nitroglycerin consumption were studied in 30 patients with chronic stable angina pectoris." | 9.07 | Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris. ( Krepp, HP, 1991) |
| "The effects of slow-release isosorbide-5-mononitrate (IS-5-MN), 25 mg once daily, bupranolol, 50 mg once daily, and their combination on exercise-induced ST-segment depression at comparable work load, maximal work load, exercise capacity, frequency of anginal episodes and sublingual nitroglycerin consumption were studied in 30 patients with chronic stable angina pectoris." | 5.07 | Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris. ( Krepp, HP, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sánchez Cascos, A | 1 |
| Espín, A | 1 |
| Ramírez, M | 1 |
| De Rábago, P | 1 |
| Bobrov, VA | 1 |
| Simorot, VN | 1 |
| Krepp, HP | 1 |
| Tarnow, J | 1 |
| Komar, K | 1 |
2 trials available for bupranolol and Angor Pectoris
| Article | Year |
|---|---|
[The clinical evaluation of the efficacy of Isoket in patients with vasospastic stenocardia].
Topics: Adult; Angina Pectoris; Bupranolol; Chi-Square Distribution; Coronary Vasospasm; Delayed-Action Prep | 1992 |
Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Bupranolol; Chronic Disease; Delayed-Action Preparations; Double-Blind Method | 1991 |
2 other studies available for bupranolol and Angor Pectoris
| Article | Year |
|---|---|
[Evaluation of anti-angina therapy by means of the treadmill test].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Bupranolol; Drug Therapy, Combination; Exerc | 1982 |
Altered hemodynamic response to dobutamine in relation to the degree of preoperative beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Bupranolol; Dobutamine; Hemodyn | 1988 |